LoginSignup
Johnson&Johnson logo

Johnson&Johnson

Stock
Stock
ISIN: US4781601046
Ticker: JNJ
US4781601046
JNJ

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 04.03.2025

$1.45

CHART BY

Frequently asked questions

What is Johnson&Johnson's market capitalization?

The market capitalization of Johnson&Johnson is $369.55B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Johnson&Johnson's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Johnson&Johnson is 26.51. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Johnson&Johnson?

Johnson&Johnson's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.797. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Johnson&Johnson's stock?

Currently, 23 analysts cover Johnson&Johnson's stock, with a consensus target price of $168.94. Analyst ratings provide insights into the stock's expected performance.

What is Johnson&Johnson's revenue over the trailing twelve months?

Over the trailing twelve months, Johnson&Johnson reported a revenue of $88.82B.

Is Johnson&Johnson paying dividends?

Yes, Johnson&Johnson is paying dividends. The next payment is scheduled for 04.03.2025, with an expected amount of .

What is the free float of Johnson&Johnson's shares?

The free float of Johnson&Johnson is 2.40B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$369.55B
EPS (TTM) 
$5.797
Free Float 
2.40B
P/E ratio (TTM) 
26.51
Revenue (TTM) 
$88.82B

Pricing

1D span
$152.84$154.32
52W span
$140.68$168.83

Analyst Ratings

The price target is $168.94 and the stock is covered by 23 analysts.

Buy

11

Hold

12

Sell

0

Information

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
US4781601046
Primary Ticker
JNJ

Knockouts

Join the conversation
Sign upLogin